We studied the frequency of TET2, SRSF2, ASXL1 and SETBP1 mutations in 145 patients with CMML and compared their outcomes with those predicted in the two Mayo Clinic prognostic models. The gene discussed is SETBP1; the disease is chronic myelomonocytic leukemia.